IVF

INVO Fertility Inc

Mar 30 • 03:32PM ET

2.29

-0.39 -14.74 %

Healthcare • Medical Devices • USA • NASD

Peers: LLY MRK ABBV PFE BMY VRTX REGN GILD AMGN BIIB

Index	-	P/E	-	EPS (ttm)	-1474.40	Insider Own	0.10%	Shs Outstand	1.62M	Perf Week	-33.77%
Market Cap	3.69M	Forward P/E	-	EPS next Y	-23.20	Insider Trans	-0.25%	Shs Float	1.60M	Perf Month	-51.88%
Enterprise Value	16.37M	PEG	-	EPS next Q	-22.00	Inst Own	99.90%	Short Float	4.18%	Perf Quarter	-45.44%
Income	-29.20M	P/S	0.53	EPS this Y	-	Inst Trans	-	Short Ratio	0.05	Perf Half Y	-93.18%
Sales	6.90M	P/B	-	EPS next Y	-	ROA	-283.90%	Short Interest	0.07M	Perf YTD	-39.28%
Book/sh	-22.34	P/C	9.23	EPS next 5Y	-	ROE	316.60%	52W High	384.00 -99.40%	Perf Year	-99.05%
Cash/sh	0.25	P/FCF	-	EPS past 3/5Y	41.42% -	ROIC	98.20%	52W Low	2.56 -10.74%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	16.23% -	Gross Margin	39.20%	Volatility	12.39% 8.55%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	2.37	EPS Y/Y TTM	2.37%	Oper. Margin	-	ATR (14)	0.47	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	0.10	Sales Y/Y TTM	11.50%	Profit Margin	-	RSI (14)	20.88	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.10	EPS Q/Q	-	SMA20	-38.94%	Beta	2.64	Target Price	20.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	28.60%	SMA50	-55.76%	Rel Volume	0.08	Prev Close	2.68
Employees	33	LT Debt/Eq	-	Earnings	Nov 17 BMO	SMA200	-93.60%	Avg Volume	1.41M	Price	2.29
IPO	Nov 11, 2008	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	102,469	Change	-14.74%

Mar-25-26 08:30AM	INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026 (GlobeNewswire) -6.21%
Mar-05-26 09:00AM	INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic (GlobeNewswire)
Mar-03-26 08:45AM	INVO Fertility's Wisconsin Clinic Joins Progyny Network (GlobeNewswire) -6.99%
Feb-19-26 08:30AM	INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic "Family Beginnings" (GlobeNewswire)
Feb-11-26 08:30AM	INVO Fertility Announces Patent Issuance for Modified INVOcell Device (GlobeNewswire)
09:00AM	Loading…
Feb-04-26 09:00AM	INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth (GlobeNewswire) -7.76%
Jan-29-26 08:30AM	INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -12.96%
Jan-24-26 09:02AM	Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Benzinga)
Jan-20-26 09:48PM	Why INVO Fertility (IVF) Stock Is Trending Overnight (Benzinga)
04:34PM	This Little-Known Fertility Stock Is Up 215% in the Past 5 Days. Should You Chase the Mysterious Penny Stock Rally Here? (Barchart)
Jan-13-26 04:15PM	INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026 (GlobeNewswire)
Dec-30-25 04:05PM	INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy (GlobeNewswire)
Dec-17-25 09:00AM	INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings" (GlobeNewswire)
Dec-02-25 09:25AM	INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Nov-28-25 01:05PM	INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic "Family Beginnings" (GlobeNewswire)
09:00AM	Loading…
Nov-25-25 09:00AM	INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025 (GlobeNewswire)
Nov-17-25 08:30AM	INVO Fertility Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-27-25 08:30AM	INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO's Wisconsin Fertility Institute (GlobeNewswire)
Sep-29-25 05:30PM	INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 (GlobeNewswire)
Aug-14-25 05:34PM	INVO Fertility Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-22-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
Jul-17-25 08:00AM	INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025 (GlobeNewswire)
Jul-09-25 09:00AM	INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing (GlobeNewswire)
08:42AM	INVO Underwriting, LLC Taps Input 1 to Power Seamless Digital Payments for Agents and Policyholders (PR Newswire)
Jun-30-25 09:00AM	INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute (GlobeNewswire)
Jun-25-25 09:00AM	INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent (GlobeNewswire)
Jun-20-25 09:00AM	INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time (GlobeNewswire)
Jun-18-25 09:00AM	INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute (GlobeNewswire)
Jun-16-25 09:00AM	INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025 (GlobeNewswire)
May-27-25 05:00PM	INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 (GlobeNewswire)
04:05PM	Loading…
May-20-25 04:05PM	INVO Fertility Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-30-25 09:00AM	INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA (GlobeNewswire)
Apr-24-25 09:00AM	INVO Fertility Confirms New Nasdaq Trading Symbol of IVF (GlobeNewswire)
Apr-14-25 07:30PM	NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations Company Renamed INVO Fertility, Inc. (GlobeNewswire)
Mar-13-25 04:30PM	NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment (GlobeNewswire)
Feb-19-25 09:15AM	NAYA Biosciences Announces Nomination of New Board Members (GlobeNewswire)
Jan-13-25 09:15AM	NAYA Biosciences Announces Pricing of $9.5 Million Public Offering (GlobeNewswire)
Jan-06-25 08:30AM	NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody (GlobeNewswire)
Oct-31-24 09:00AM	NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-24-24 09:00AM	NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma (GlobeNewswire)
Oct-21-24 09:00AM	INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences (GlobeNewswire)
Oct-14-24 09:18AM	INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) (GlobeNewswire)
Aug-14-24 09:00AM	INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA (GlobeNewswire)
May-15-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024 (InvestorPlace)
04:15PM	INVO Reports Record First Quarter 2024 Financial Results (GlobeNewswire)
May-14-24 07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Apr-17-24 08:16AM	Why Is Invo Bioscience (INVO) Stock Up 85% Today? (InvestorPlace)
Apr-16-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023 (InvestorPlace)
04:59PM	INVO Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-23-24 08:00AM	NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) (GlobeNewswire)
Jan-17-24 08:00AM	INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors (GlobeNewswire)
Dec-11-23 08:00AM	NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal (PR Newswire)
Dec-06-23 09:00AM	NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies (PR Newswire)
Nov-28-23 09:00AM	INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement (PR Newswire)
Nov-13-23 04:01PM	INVO Reports Record Third Quarter 2023 Financial Results (PR Newswire)
08:15AM	BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger (News Direct)
Nov-10-23 09:00AM	NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger (PR Newswire)
Nov-09-23 04:40PM	INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants (PR Newswire)
Oct-27-23 09:00AM	Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023 (PR Newswire)
Oct-24-23 10:08AM	Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm (GlobeNewswire)
08:45AM	Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments (PR Newswire)
Oct-23-23 01:40PM	Why Is INVO Bioscience (INVO) Stock Up 325% Today? (InvestorPlace)
07:30AM	INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company (PR Newswire)
Oct-11-23 09:00AM	INVO to Participate in the Lytham Partners Fall 2023 Investor Conference (PR Newswire)
Sep-29-23 04:05PM	INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS (PR Newswire)
Sep-28-23 12:30PM	INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET (PR Newswire)
Aug-14-23 04:05PM	INVO Reports Second Quarter 2023 Financial Results (PR Newswire)
Aug-11-23 08:00AM	INVO Closes Acquisition of Wisconsin Fertility Institute (PR Newswire)
Aug-09-23 04:15PM	INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (PR Newswire)
Aug-08-23 01:55PM	INVO Bioscience Announces Closing of $4.5 Million Public Offering (PR Newswire)
Aug-04-23 09:00AM	INVO Bioscience Announces Pricing of $4.5 Million Public Offering (PR Newswire)
Aug-03-23 08:00AM	INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value (PR Newswire)
Jul-27-23 09:26AM	INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023 (PR Newswire)
Jun-27-23 09:00AM	INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device (PR Newswire)
May-15-23 04:05PM	INVO Reports First Quarter 2023 Financial Results (PR Newswire)
May-08-23 04:15PM	INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (PR Newswire)
Apr-17-23 04:05PM	INVO Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire)
Apr-11-23 05:30PM	INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023 (PR Newswire)
Apr-05-23 09:00AM	INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek (PR Newswire)
Mar-30-23 05:25PM	INVO Provides Preliminary Update on FY2022 Financial Results (PR Newswire)
Mar-27-23 05:06PM	INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering (PR Newswire)
Mar-24-23 08:00AM	INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market (PR Newswire)
Mar-20-23 09:00AM	INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute (PR Newswire)
Jan-05-23 09:00AM	INVO Bioscience Enters Distribution Agreement for Taiwan (PR Newswire)
Jan-03-23 09:00AM	INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center (PR Newswire)
Nov-30-22 09:30AM	First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology (PR Newswire)
Nov-14-22 04:05PM	INVO Bioscience Reports Third Quarter 2022 Financial Results (PR Newswire)
Nov-10-22 04:15PM	INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 (PR Newswire)
Nov-01-22 09:00AM	INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Oct-21-22 09:00AM	INVOcell Review Published in Current Opinion in Obstetrics and Gynecology (PR Newswire)
Oct-17-22 09:00AM	INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Sep-22-22 09:00AM	Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly (PR Newswire)
Aug-25-22 09:00AM	INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz (PR Newswire)
Aug-15-22 04:05PM	INVO Bioscience Reports Second Quarter 2022 Financial Results (PR Newswire)
Aug-04-22 04:15PM	INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 (PR Newswire)
Jul-07-22 08:00AM	INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment (PR Newswire)
May-16-22 04:15PM	INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China (PR Newswire)
04:05PM	INVO Bioscience Reports First Quarter 2022 Financial Results (PR Newswire)
May-09-22 04:30PM	INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 (PR Newswire)

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Szot Matthew K	Director	Dec 03 '25	Sale	1.52	4	6	3	Dec 05 09:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IVF

INVO Fertility Inc

Upgrade your Finviz experience